Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 Last updated on 16 January 2023
Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 Last updated on 16 January 2023
consolidated gross profit in Q2-2016 in amount of THB 806 million. (Separated gross loss of THB 167 million for Q2-2017 and separated gross profit of THB 330 million for Q2-2016). The main reason of the
regard, the company would like to report operating results for the second quarter of 2020 as follows Consolidated Financial Statements Ekachai Medical Care Public Company Limited and its subsidiaries
Seamico Securities Public Company Limited (“The Company”) would like to report operating result that has been examined by our auditor for the year ended December 31, 2017 as follows: The consolidated
statement for the year period ended December 31, 2018, details are as follows: The operating results of the consolidated financial statement for the year period ended December 31, 2018 The Consolidated
Financial performances Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% Q1/2019 Q1/2018 Q1/2018 Q1/2017 Revenues from sales and services of medical equipment 460,711 366,698 26% 382,283 320,648
the consolidated financial statements of the Company and its subsidiaries for the first quarter ended 31st March 2020. The Company reported a consolidated loss (attributable to equity holders of the
674,235,360 or approximately 34% of the net profit of consolidated financial statements, which will be paid from the unappropriated retained earnings with 30% corporate income tax, wherein individual